1. Home
  2. ABEO vs MBCN Comparison

ABEO vs MBCN Comparison

Compare ABEO & MBCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • MBCN
  • Stock Information
  • Founded
  • ABEO 1974
  • MBCN 1901
  • Country
  • ABEO United States
  • MBCN United States
  • Employees
  • ABEO N/A
  • MBCN N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • MBCN Major Banks
  • Sector
  • ABEO Health Care
  • MBCN Finance
  • Exchange
  • ABEO Nasdaq
  • MBCN Nasdaq
  • Market Cap
  • ABEO 256.9M
  • MBCN 234.0M
  • IPO Year
  • ABEO 1980
  • MBCN N/A
  • Fundamental
  • Price
  • ABEO $6.24
  • MBCN $29.35
  • Analyst Decision
  • ABEO Strong Buy
  • MBCN Hold
  • Analyst Count
  • ABEO 5
  • MBCN 1
  • Target Price
  • ABEO $17.80
  • MBCN $32.00
  • AVG Volume (30 Days)
  • ABEO 1.7M
  • MBCN 8.6K
  • Earning Date
  • ABEO 05-15-2025
  • MBCN 07-17-2025
  • Dividend Yield
  • ABEO N/A
  • MBCN 2.86%
  • EPS Growth
  • ABEO N/A
  • MBCN N/A
  • EPS
  • ABEO N/A
  • MBCN 2.00
  • Revenue
  • ABEO N/A
  • MBCN $66,931,000.00
  • Revenue This Year
  • ABEO N/A
  • MBCN $15.08
  • Revenue Next Year
  • ABEO $383.07
  • MBCN $5.02
  • P/E Ratio
  • ABEO N/A
  • MBCN $14.64
  • Revenue Growth
  • ABEO N/A
  • MBCN N/A
  • 52 Week Low
  • ABEO $3.93
  • MBCN $20.61
  • 52 Week High
  • ABEO $7.32
  • MBCN $34.00
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 56.57
  • MBCN 57.30
  • Support Level
  • ABEO $5.93
  • MBCN $28.66
  • Resistance Level
  • ABEO $7.17
  • MBCN $29.70
  • Average True Range (ATR)
  • ABEO 0.44
  • MBCN 0.63
  • MACD
  • ABEO -0.01
  • MBCN -0.10
  • Stochastic Oscillator
  • ABEO 50.00
  • MBCN 67.65

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About MBCN Middlefield Banc Corp.

Middlefield Banc Corp is a bank holding company. It offers customers, banking services including checking, savings, negotiable order of withdrawal (NOW) accounts, money market accounts, time deposits, commercial loans, real estate loans, a variety of consumer loans, safe deposit facilities, and travelers' checks. It also provides online banking and bill payment services to individuals and online cash management services to business customers.

Share on Social Networks: